Investment
Features
FeesSafety
Academy
More
Pluang+

Labcorp declares $0.72 per share dividend payable June 11, 2026 to May 29 record holders

Company Fundamentals
09 Apr 2026
PRNewsWire
View Source
Bullish
Labcorp declares $0.72 per share dividend payable June 11, 2026 to May 29 record holders

Labcorp Holdings Inc. announced a cash dividend of $0.72 per share, payable on June 11, 2026, to shareholders recorded by May 29, 2026. This dividend reflects Labcorp's ongoing commitment to returning value to its investors. Labcorp is a global leader in laboratory services, supporting medical and pharmaceutical advancements worldwide. Investors can expect the dividend as a steady income from their holdings in the company.

More News

AlphaPepe crypto presale raises $3.1M with 12,600+ holders; new exchange partnership, possibly Binance, expected soon.

AlphaPepe crypto presale raises $3.1M with 12,600+ holders; new exchange partnership, possibly Binance, expected soon.

AlphaPepe's crypto presale has raised over $3.1 million with more than 12,600 holders, showing strong retail demand before its public exchange debut. The project features a live AI-powered DEX called AlphaSwap and is led by an ex-Shibarium developer,...

Market News
Bullish
2 hours ago
iCAUR debuts V25 and showcases customization at 2026 International User Summit in Wuhu, expanding global reach.

iCAUR debuts V25 and showcases customization at 2026 International User Summit in Wuhu, expanding global reach.

The 2026 iCAUR International User Summit in Wuhu, China, introduced the new iCAUR V25, expanding the V-Series lineup alongside the V23 and V27. The event highlighted the brand's Future Classic Design philosophy, vehicle customization, and user co-cre...

Market News
Bullish
2 hours ago
HUTCHMED closes exclusive license deal with GSK for KRAS-EGFR antibody therapy outside China.

HUTCHMED closes exclusive license deal with GSK for KRAS-EGFR antibody therapy outside China.

HUTCHMED has finalized an exclusive license agreement with GSK granting GSK rights to develop and commercialize HMPL-A830, a novel KRAS-EGFR antibody conjugate therapy, outside China, Hong Kong, Macau, and Taiwan. This therapy targets cancers with KR...

Company Fundamentals
Bullish
3 hours ago
Injective and BDACS explore won-backed token KRW1 to settle assets, bypassing dollar stablecoins.

Injective and BDACS explore won-backed token KRW1 to settle assets, bypassing dollar stablecoins.

Injective and South Korean digital asset custodian BDACS signed a memorandum of understanding to explore using KRW1, a token backed one-to-one by Korean won reserves, for settling tokenized assets directly in won on Injective's blockchain. This initi...

Protocol Fundamentals
Bullish
4 hours ago
CME Group launches Uniswap Futures as a16z holds 10% of UNI supply amid price support at $7

CME Group launches Uniswap Futures as a16z holds 10% of UNI supply amid price support at $7

CME Group has introduced Uniswap (UNI) and Micro UNI Futures, enabling institutional investors to trade regulated derivatives on UNI. This move integrates decentralized finance tokens into traditional markets and offers new risk management tools. Mea...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App